Pfizer Completes Sale of Consumer Healthcare Business

22-Dec-2006

Pfizer Inc said that it has completed the sale of its Pfizer Consumer Healthcare business to Johnson & Johnson for $16.6 billion or about $13.5 billion in after-tax proceeds.

"The proceeds from this sale, combined with our strong operating cash flow, give us the flexibility to invest in the growth of our core pharmaceutical business while enhancing total return to shareholders through dividends and share purchases," said Jeffrey B. Kindler, Pfizer chairman and CEO.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!